Home › Companies › Royalty Pharma plc › 2025-2026
Compiled from SEC Form N-PX filings and Royalty Pharma plc’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Royalty Pharma plc in the interactive database Compare manager voting policies
These tallies are Royalty Pharma plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Pablo Legorreta | 458,242,360 | 29,448,236 | 168,578 | -- | 20,320,929 | Majority: yes |
| Elect Director: Ted Love, M.D. | 464,556,053 | 23,135,217 | 167,904 | -- | 20,320,929 | Majority: yes |
| Elect Director: Bonnie Bassler, Ph.D. | 486,078,663 | 1,615,471 | 165,040 | -- | 20,320,929 | Majority: yes |
| Elect Director: Vlad Coric, M.D. | 433,218,530 | 54,472,087 | 168,557 | -- | 20,320,929 | Majority: yes |
| Elect Director: Catherine Engelbert | 485,200,369 | 2,492,809 | 165,996 | -- | 20,320,929 | Majority: yes |
| Elect Director: Carole Ho, M.D. | 487,136,029 | 557,922 | 165,223 | -- | 20,320,929 | Majority: yes |
| Elect Director: David Hodgson | 479,933,527 | 7,733,381 | 192,266 | -- | 20,320,929 | Majority: yes |
| Elect Director: Gregory Norden | 481,576,664 | 6,090,949 | 191,561 | -- | 20,320,929 | Majority: yes |
| Elect Director: Elizabeth Weatherman | 487,564,658 | 128,998 | 165,518 | -- | 20,320,929 | Majority: yes |
| Proposal 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers: | 476,044,602 | 11,067,486 | 747,086 | -- | 20,320,929 | Majority: yes |
| Proposal 3. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm: | 506,307,829 | 832,217 | 1,040,057 | -- | -- | Majority: yes |
| Proposal 5. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts: | 478,165,378 | 8,935,552 | 758,244 | -- | 20,320,929 | Majority: yes |
| There were no broker non-votes on this proposal. Proposal 7. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor: | 487,092,662 | 575,800 | 190,712 | -- | 20,320,929 | Majority: yes |
| Proposal 8. To approve the terms of the agreements and counterparties pursuant to which the Company may purchase its Class A ordinary shares: | 474,475,427 | 12,499,628 | 884,119 | -- | 20,320,929 | Majority: yes |
| Proposal 9. To authorize the Board of Directors to allot shares: | 469,111,384 | 18,568,396 | 179,394 | -- | 20,320,929 | Majority: yes |
| Proposal 10. To authorize the Board of Directors to allot shares without rights of pre-emption: | 445,653,078 | 42,016,406 | 189,690 | -- | 20,320,929 | Majority: yes |
Source: Royalty Pharma plc, Form 8-K — read the filing on EDGAR.
Each item below shows how the 567 asset managers that disclosed a Royalty Pharma plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Royalty Pharma plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-06-04.
Combines 11 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers:”): 476,044,602 for, 11,067,486 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 562 asset managers below cast 98% of the shares they voted on this item FOR (376,823,495 for, 8,227,035 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 82,134,119 | 0 | 0 | 0 | For |
| Morgan Stanley | 45,249,914 | 0 | 0 | 0 | For |
| Fidelity | 42,263,269 | 0 | 0 | 0 | For |
| BlackRock | 26,135,344 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 11,586,693 | 0 | 0 | 0 | For |
| Vanguard | 11,573,353 | 25 | 2 | 0 | For |
| Victory Capital | 10,770,260 | 0 | 0 | 0 | For |
| State Street | 8,340,816 | 10,152 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 7,872,174 | 0 | 0 | 0 | For |
| Invesco | 6,697,633 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,580,633 | 0 | 0 | 0 | For |
| Charles Schwab | 5,972,556 | 0 | 0 | 0 | For |
| Caledonia (Private) Investments Pty Ltd | 5,051,550 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 4,663,534 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,795,116 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO | 3,585,063 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 3,315,813 | 0 | 0 | 0 | For |
| Amundi | 566,094 | 2,108,226 | 0 | 0 | Against |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Northern Trust | 2,653,449 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| AQR | 2,485,203 | 0 | 0 | 0 | For |
| NEW SOUTH CAPITAL MANAGEMENT INC | 2,376,063 | 0 | 0 | 0 | For |
| Regal Partners Ltd | 2,307,376 | 0 | 0 | 0 | For |
| Dorsey Asset Management, LLC | 2,276,570 | 0 | 0 | 0 | For |
Showing the 25 largest of 562 asset managers. See all 562 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 5. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts:”): 478,165,378 for, 8,935,552 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 124 asset managers below cast 99.4% of the shares they voted on this item FOR (148,532,951 for, 755,030 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| BlackRock | 26,135,344 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,958 | 18 | 2 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Caledonia (Private) Investments Pty Ltd | 5,051,550 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| STOREBRAND ASSET MANAGEMENT AS | 782,703 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 595,547 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Pablo Legorreta”): 458,242,360 for, 29,448,236 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.6% of the shares they voted on this item FOR (124,223,718 for, 451,760 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,904 | 75 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 6 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Ted Love, M.D.”): 464,556,053 for, 23,135,217 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99% of the shares they voted on this item FOR (123,302,824 for, 1,372,654 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,923,905 | 9,032 | 0 | 0 | For |
| Vanguard | 8,258,234 | 22,745 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 0 | 596,935 | 0 | 0 | Against |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Bonnie Bassler, Ph.D.”): 486,078,663 for, 1,615,471 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (124,655,476 for, 2 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,977 | 2 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 6 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Vlad Coric, M.D.”): 433,218,530 for, 54,472,087 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 93% of the shares they voted on this item FOR (116,150,180 for, 8,505,297 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 6,027,226 | 2,253,752 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,740 | 2,937,710 | 0 | 0 | Against |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 0 | 528,307 | 0 | 0 | Against |
| Equitable | 360,849 | 138,721 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Catherine Engelbert”): 485,200,369 for, 2,492,809 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (124,664,472 for, 6 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,973 | 6 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 6 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Carole Ho, M.D.”): 487,136,029 for, 557,922 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (124,664,476 for, 2 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,977 | 2 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: David Hodgson”): 479,933,527 for, 7,733,381 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.8% of the shares they voted on this item FOR (124,424,091 for, 240,385 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,961 | 16 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Gregory Norden”): 481,576,664 for, 6,090,949 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (124,641,365 for, 23,113 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,963 | 16 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Elect Director: Elizabeth Weatherman”): 487,564,658 for, 128,998 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (124,641,381 for, 23,097 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,979 | 0 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 3. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm:”): 506,307,829 for, 832,217 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 100% of the shares they voted on this item FOR (124,654,976 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,977 | 0 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“There were no broker non-votes on this proposal. Proposal 7. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor:”): 487,092,662 for, 575,800 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 108 asset managers below cast 100% of the shares they voted on this item FOR (124,674,478 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,979 | 0 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 10. To authorize the Board of Directors to allot shares without rights of pre-emption:”): 445,653,078 for, 42,016,406 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 107 asset managers below cast 99% of the shares they voted on this item FOR (122,913,884 for, 1,865,807 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 6,810,309 | 1,470,669 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 139,847 | 0 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2026-06-04.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 107 asset managers below cast 100% of the shares they voted on this item FOR (124,620,343 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,977 | 0 | 2 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2026-06-04.
99.9% fund support · no official result
The 107 asset managers below cast 99.9% of the shares they voted on this item FOR (124,617,328 for, 2 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,977 | 2 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 0 | 139,847 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2026-06-04.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 8. To approve the terms of the agreements and counterparties pursuant to which the Company may purchase its Class A ordinary shares:”): 474,475,427 for, 12,499,628 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 107 asset managers below cast 99.9% of the shares they voted on this item FOR (124,759,654 for, 35 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,941 | 35 | 2 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,149,197 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2026-06-04.
Combines 2 wordings of this item as funds reported it.
99.8% fund support · no official result
The 107 asset managers below cast 99.8% of the shares they voted on this item FOR (124,598,368 for, 181,323 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 37,466,076 | 0 | 0 | 0 | For |
| Fidelity | 23,338,697 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,932,937 | 0 | 0 | 0 | For |
| Vanguard | 8,280,930 | 48 | 0 | 0 | For |
| BlackRock | 7,765,898 | 0 | 0 | 0 | For |
| Victory Capital | 6,902,683 | 0 | 0 | 0 | For |
| Invesco | 3,090,537 | 0 | 0 | 0 | For |
| Charles Schwab | 2,940,450 | 0 | 0 | 0 | For |
| Transamerica | 2,667,195 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 2,500,000 | 0 | 0 | 0 | For |
| Brighthouse | 2,009,350 | 139,847 | 0 | 0 | For |
| T. Rowe Price | 1,410,745 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,073,575 | 0 | 0 | 0 | For |
| Goldman Sachs | 922,117 | 0 | 0 | 0 | For |
| First Trust | 759,647 | 0 | 0 | 0 | For |
| Pacific Life | 738,489 | 0 | 0 | 0 | For |
| TIAA | 727,951 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 681,715 | 0 | 0 | 0 | For |
| State Street | 596,935 | 0 | 0 | 0 | For |
| JPMorgan | 593,735 | 0 | 0 | 0 | For |
| AQR | 559,517 | 0 | 0 | 0 | For |
| SEI | 528,307 | 0 | 0 | 0 | For |
| Equitable | 499,570 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 493,508 | 0 | 0 | 0 | For |
| Thrivent | 490,731 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2025-05-12 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
95% Majority: yes · of votes cast
Royalty Pharma plc’s own tally for this item (“Proposal 3. To approve, on a non-binding advisory basis, the compensation that may become payable to the Company's named executive officers in connection with the Transaction:”): 420,544,944 for, 20,056,306 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 4 asset managers below cast 100% of the shares they voted on this item FOR (142,400 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Investment Management Corp of Ontario | 117,200 | 0 | 0 | 0 | For |
| PENSIOENFONDS RAIL & OV | 19,900 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 4,800 | 0 | 0 | 0 | For |
| NORRIS PERNE & FRENCH LLP/MI | 500 | 0 | 0 | 0 | For |
Meeting held 2025-05-12 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
86% fund support · no official result
The 4 asset managers below cast 86% of the shares they voted on this item FOR (122,500 for, 19,900 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Investment Management Corp of Ontario | 117,200 | 0 | 0 | 0 | For |
| PENSIOENFONDS RAIL & OV | 0 | 19,900 | 0 | 0 | Against |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 4,800 | 0 | 0 | 0 | For |
| NORRIS PERNE & FRENCH LLP/MI | 500 | 0 | 0 | 0 | For |
Ranked by the number of Royalty Pharma plc shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 436,790,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 18.80% |
| 2 | Morgan Stanley | 10.36% |
| 3 | Fidelity | 9.68% |
| 4 | BlackRock | 5.98% |
| 5 | Swedbank Robur Fonder AB | 2.65% |
| 6 | Vanguard | 2.65% |
| 7 | Victory Capital | 2.47% |
| 8 | State Street | 1.91% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.80% |
| 10 | Invesco | 1.53% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Legorreta G. Pablo | 23.30% | 13D |
| RPI US Partners 2019, LP | 22.50% | DEF14A |
| Morgan Stanley | 8.91% | DEF14A |
| Capital International Investors | 7.50% | DEF14A |
| FMR LLC | 6.39% | DEF14A |
| BlackRock | 5.93% | 13F |
| FMR (Fidelity) | 5.76% | 13F |
| R & H Trust Co. (Guernsey) Limited | 5.55% | 13D |
| PL RPH Holdings, LLC | 3.06% | DEF14A |
| State Street | 2.52% | 13F |
Percentages above are of 436,790,000 shares outstanding, as reported by Royalty Pharma plc on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Royalty Pharma plc’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Royalty Pharma plc's shareholder meeting held 2026-06-04, in the 2025-2026 proxy season, 567 asset managers reported how they voted in their SEC Form N-PX filings, covering 9,509 separate fund positions. Their filings are grouped here into 20 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Royalty Pharma plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
Royalty Pharma plc proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).